Please assess the completion status of the following clinical trial:

Trial Title: Cannabis for Spasticity in Multiple Sclerosis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1/PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of clinically definite multiple sclerosis as defined by Poser criteria~* Moderate or severe spasticity~* Age 21 or older~* Must live close to the Sacramento, CA area~Exclusion Criteria:~* Preexisting pulmonary conditions, including poorly controlled asthma, chronic bronchitis, emphysema, bronchiectasis, and other significant pulmonary disorders~* Preexisting cardiac conditions, including ischemic heart disease, congestive heart failure, and other significant cardiac disorders~* Inability to abstain from tobacco or marijuana smoking, or use of alcohol or sedative or hypnotic medications during the duration of the study~* Pre-existing dementia, mania, depression or schizophrenia or other poorly controlled psychiatric illness~* Past history of abuse of recreational drugs, including marijuana and alcohol in the last 12 months~* History of or currently meets DSM-IV criteria for dependence on cannabis~* Use of cannabis, marijuana, or THC in the last four weeks~* Preexisting dementia, mania, depression, or schizophrenia or other poorly controlled psychiatric illness~* Exacerbation of MS within 30 days prior to screening visit~* Current use of cyclophosphamide, mitoxantrone, or cladribine~* Arthritis, bony and soft tissue disorders interfering with spasticity measures~* Inability to provide informed consent~* Recent cannabis use of more than twice per week one month prior to study entry~* For females of child bearing potential, inability to comply with adequate contraception

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1) Inhaled Cannabis (Type: ACTIVE_COMPARATOR): Inhaled cannabis is compared to oral placebo.
- 2) Oral THC (Type: ACTIVE_COMPARATOR): Inhaled placebo is compared to oral THC.
- 3) Placebo (Type: PLACEBO_COMPARATOR): Inhaled placebo is compared to oral placebo.

Based on this trial design, predict the completion outcome and termination type (if applicable).